A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Clinical trial NCT03019536 · COMPLETED

Trial details

NCT number: NCT03019536
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2017-01-31
Primary completion: 2019-06-05
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.